Introduction
Anti-mullerian hormone (AMH) in largely expressed throughout folliculogenesis (by granulosa cells in ovarian follicles) but highest in pre-antral and small antral steges (<4mm) diameter of development. Serum AMH level may represent the quality and quantity of ovarian follicular 1 pool. 1 AMH-production decreases and then stops as follicles grow. There is almost no AMH made in follicles over-8mm. 2 AMH-blood level are thought to reflect the size of the remaining egg supply or "ovarian reserve" and can be measured any times of menstrual cycle. 3 AMH is a focus of interest in polycystic ovary syndrome (PCOS), there appear two groups of women with PCOS who can be distinguished by their AMH level. 4 AMH is directly related to the number of Oocyte that are suitable at IVF, its value is in identificat ion of women likely to over responds and thus be at risk of ovarian hyperstimultion syndrome and conversely, women where a poor response in predicted, to help manage expectations. 5 AMH-is bear discriminator than FSH. AMH is frequently to as reflecting the ovarian response meaning the number of Follicles that can be sensitized to grown by the administration of FSH. 6 The term "Overran reserve" is also used, perhaps more accurately, to mean the post of primodial non-growing follicles within the ovary thus AMH-can be correctly surge to reflect the ovarian reserve. 7 As AMH is produced by small follicles whose numbers reflect the primordial pool, concentrations decline with age in adult women. 8 
Conclusion
AMH gives an evaluation tools in either reduced and elevated levels in PCOS women. AMH is considered as a useful test to study folliculo genesis and ovarian potential in various situations of fertility and for identification of PCOS. To avoid the possibility of subjecting patients at risk of ineffective assisted reproductive technology and using hormonal stimulation or in vitro embryo transfer needs careful clinical assessment.
